The article you requested is
Academic Highlights: New Insights Into Genetics and Pathophysiology of Alzheimer's Disease: What Are the Clinical and Therapeutic Implications?
J Clin Psychiatry 2000;61:307-315
Copyright 2000 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
- Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Genetic findings have made an
important contribution to the understanding
of Alzheimer’s disease. The
mutations in β-amyloid precursor protein
(βAPP) and presenilin 1 (PS1)
transmitted in a simple Mendelian manner
have provided the basis for our
understanding of the central role of
β-amyloid in all cases of Alzheimer’s.
Dr. Mullan suggested that whereas
variability at the apolipoprotein E
(APOE) locus is clearly associated with
the occurrence of disease, for many
other genes such clarity is less established.